METHODS	Pretreatment ethylenediamine tetracetic acid plasma TIMP-1 was assayed from 251 patients who were enrolled in a Phase III , second-line , hormone therapy trial , and from a control group of 50 healthy , postmenopausal women by using the TIMP-1 enzyme-linked immunosorbent assay .\